Data from a consecutive series of 13 patients with stage III malignant melanoma indicate that patients with BRAFV600E-mutant marginally resectable or irresectable melanoma are able to derive clinical benefit from neoadjuvant BRAF inhibition. This approach enabled all patients to undergo surgical resection, which

中文翻译：

---

黑色素瘤：抑制辅佐性BRAF可切除

来自连续13例III期恶性黑色素瘤患者系列的数据表明，BRAFV600E突变型边缘可切除或不可切除的黑色素瘤患者能够从新辅助BRAF抑制中获得临床收益。这种方法使所有患者都可以进行手术切除，